Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EWTX | Edgewise Therapeutics, Inc. | Dec 24, 2024 | 4 | -$616K | 4 | Dec 27, 2024 | Chief Development Officer |
EWTX | Edgewise Therapeutics, Inc. | Aug 12, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Chief Development Officer |
EWTX | Edgewise Therapeutics, Inc. | Aug 17, 2023 | 1 | $0 | 4 | Aug 18, 2023 | Chief Development Officer |
EWTX | Edgewise Therapeutics, Inc. | Dec 30, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Chief Development Officer |
EWTX | Edgewise Therapeutics, Inc. | Dec 19, 2022 | 0 | $0 | 3 | Dec 22, 2022 | Chief Development Officer |
RCOR | Renovacor, Inc. | Dec 1, 2022 | 6 | $0 | 4 | Dec 5, 2022 | Chief Medical Officer |
RCOR | Renovacor, Inc. | Jan 24, 2022 | 2 | $0 | 4 | Jan 26, 2022 | Chief Medical Officer |
RCOR | Renovacor, Inc. | Dec 20, 2021 | 1 | $0 | 4 | Dec 22, 2021 | Chief Medical Officer |
RCOR | Renovacor, Inc. | Sep 3, 2021 | 1 | $0 | 4 | Sep 8, 2021 | Chief Medical Officer |
RCOR | Renovacor, Inc. | Sep 2, 2021 | 0 | $0 | 3 | Sep 7, 2021 | Chief Medical Officer |
PROK | Social Capital Suvretta Holdings Corp. III | Jun 29, 2021 | 0 | $0 | 3 | Jun 29, 2021 | Director |